Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Apr
7
2021
A Real Party-in-Interest Determination is Final and Non-Appealable, Including Denial of Related Motion to Dismiss and Discovery Finnegan
Apr
7
2021
Federal Circuit Confirms the PTAB’s Authority to Deinstitute IPR Proceedings Finnegan
Apr
6
2021
Revealing Manufacturer Information Does Not Warrant Filing an Amended Complaint Under Seal Finnegan
Apr
6
2021
Federal Circuit: Mandamus Petitions Challenging Institution Denial Are Unlikely to Show Right to Relief Finnegan
Apr
1
2021
Spotlight on Upcoming Oral Arguments – April 2021 Finnegan
Apr
1
2021
Blame the Lawyer: In Exceptional Case, Plaintiff’s Attorney Liable for Court and Appellate Fees McDermott Will & Emery
Apr
1
2021
Set Phase to Subject Matter Ineligible: More Accurate Haplotype Phase Method Still Abstract McDermott Will & Emery
Apr
1
2021
Triple Trouble: Unauthorized Trademark Use among Organizations with Nearly Identical Name McDermott Will & Emery
Mar
31
2021
Good News/Bad News: Patent Owners and Petitioners Both Make Gains in CAFC Uniloc Decision Mintz
Mar
30
2021
Biden’s Nominee to the Fed. Cir. is Perkins Coie Litigator Schwegman, Lundberg & Woessner, P.A.
Mar
29
2021
§ 314(d) Bar Does Not Defeat Federal Circuit’s Mandamus Jurisdiction Finnegan
Mar
24
2021
The Road Less Traveled: IPR Denial Decisions Appealable via Mandamus McDermott Will & Emery
Mar
24
2021
Waiver in PTO Trademark Appeals Applies “Per Decision, Not Per Case” McDermott Will & Emery
Mar
24
2021
For Certain Not Secret Now: Court Declines to Seal Alleged Trade Secret in Amended Complaint McDermott Will & Emery
Mar
23
2021
Is It Hindsight or Was It Already There? Finnegan
Mar
20
2021
Subject Matter Eligibility for Medical Diagnostic Claims – a Possible Path Forward? Squire Patton Boggs (US) LLP
Mar
19
2021
CAFC Affirms PTAB’s Rejection of Patent Application as Abstract Finnegan
Mar
18
2021
Federal Circuit Affirms PTAB’s Rejection of Patent Application as Abstract Finnegan
Mar
17
2021
No Estoppel in the Name of Different Interests and Claims McDermott Will & Emery
Mar
17
2021
Can’t Camouflage Express Trademark Contract Terms McDermott Will & Emery
Mar
17
2021
Doctrine of Equivalents Analysis Should Not Be Simple Binary Comparison McDermott Will & Emery
Mar
17
2021
Method for Determining Haplotype Phase Found Subject Matter Ineligible McDermott Will & Emery
Mar
15
2021
“Winning” Prosecution Arguments Can Invalidate Your Patent As Indefinite Sheppard, Mullin, Richter & Hampton LLP
Mar
15
2021
CAFC Tightens Enablement Standard for Functional Claiming of Antibodies Proskauer Rose LLP
Mar
13
2021
In re: Board of Trustees of Stanford: “Big Data” Personalized Medicine is an Abstract Idea Schwegman, Lundberg & Woessner, P.A.
Mar
11
2021
Knowledge of Patent, Evidence of Infringement Are Necessary, but Not Sufficient, to Establish Willfulness McDermott Will & Emery
Mar
11
2021
Click Fraud: Predicate to False Designation of Origin McDermott Will & Emery
Mar
11
2021
First-to-File Rule Requires That Action Could Have Been Brought in Transferee Forum McDermott Will & Emery
Mar
11
2021
Corresponding Structure Necessary to Support ‘Module’ Claim Element McDermott Will & Emery
Mar
10
2021
Patent Buyers Beware: Supreme Court Ruling in Hologic May Merit Additional Contractual Protections Mintz
Mar
10
2021
IPR and CBM Statistics for Final Written Decisions Issued in December 2020 and January 2021 Finnegan
Mar
9
2021
Corellium’s Bite of Apple’s iOS for Security Research Is Fair Use but DMCA Claims Loom Finnegan
Mar
9
2021
The Seventh Amendment Does Not Bar Pre-Verdict Supplemental Damages Finnegan
Mar
8
2021
Software Claims Lacking an Algorithm Are Held Indefinite for Lack of Sufficient Structure Finnegan
Mar
5
2021
Sanctions Imposed Against Litigant for “Abusive” Litigation Conduct Finnegan
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters